
To illuminate the unseen layers of cellular heterogeneity with our proprietary powerful multi-omics single-cell platform, thereby accelerating discoveries and driving better health and wellbeing.
Our multi-modal DNA + RNA single-cell profiling technologies empower researchers to gain a higher-level perspective on their samples and benefit from it. It’s akin to granting color-blind individuals the ability to perceive colors.

Users can only obtain vague information from their samples.

Users can access partial information, but it remains insufficient to uncover the secrets hidden within their samples.

Users can decode hidden insights and gain deeper understanding of samples, enabling them to advance exploration in their respective fields.
We identified a unique transcriptionally normal-like tumor clone by analyzing a 2-year frozen astrocytoma sample, demonstrating that performing single-cell multi-omics interrogation on biobanked tissue by scONE-seq could enable previously unidentified discoveries in tumor biology.


Our research achievements have been recognized as one of Hong Kong’s Top Ten Science and Technology Innovation News of 2023.
Our technologies have been endorsed and supported by the Hong Kong Government and The Hong Kong University of Science and Technology (HKUST), backed by financial support amounting to hundreds of thousands of HKD.
From left to right: Dr. Xuyan LIN, Dr. Angela Ruohao WU, and Mr. Zehaoyu WU

